loadpatents
name:-0.054008960723877
name:-0.045095920562744
name:-0.0096678733825684
Wang; Zhaoyin Patent Filings

Wang; Zhaoyin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Zhaoyin.The latest application filed is for "alkylboronic acids as arginase inhibitors".

Company Profile
7.46.46
  • Wang; Zhaoyin - Shanghai CN
  • Wang; Zhaoyin - Guangzhou CN
  • Wang; Zhaoyin - Richmond CA
  • Wang; Zhaoyin - Nanjing CN
  • Wang; Zhaoyin - Kirkland CA
  • Wang; Zhaoyin - Quebec CA
  • Wang; Zhaoyin - Pierrefonds CA
  • Wang; Zhaoyin - Pierrefond CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted bisphenyl butanoic ester derivatives as NEP inhibitors
Grant 11,426,375 - Chai , et al. August 30, 2
2022-08-30
Alkylboronic Acids As Arginase Inhibitors
App 20220251116 - Wang; Zhaoyin ;   et al.
2022-08-11
Heterocyclic Compounds As Inhibitors Of Kras G12c
App 20220153741 - Wang; Zhaoyin ;   et al.
2022-05-19
Cyclic Molecules As Bruton's Tyrosine Kinase Inhibitor
App 20220081445 - WANG; Zhaoyin ;   et al.
2022-03-17
Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor
Grant 11,053,207 - Wang , et al. July 6, 2
2021-07-06
Heterobicyclic Carboxylic Acids and Salts Thereof
App 20210079013 - Zhou; Gang ;   et al.
2021-03-18
Spiro Compound As Indoleamine-2,3-dioxygenase Inhibitor
App 20210047290 - WANG; Zhaoyin ;   et al.
2021-02-18
Heterobicyclic Carboxylic Acids for Treating Cancer or Inflammatory Diseases
App 20200352906 - Zhou; Gang ;   et al.
2020-11-12
Heterocyclic Compounds As Arginase Inhibitors
App 20200325161 - Wang; Zhaoyin ;   et al.
2020-10-15
Heterocyclics As Inhibitors Of Fibroblast Growth Factor Receptor
App 20200253978 - Kind Code
2020-08-13
Substituted Bisphenyl Butanoic Ester Derivatives As Nep Inhibitors
App 20200246295 - Kind Code
2020-08-06
Substituted bisphenyl butanoic ester derivatives as NEP inhibitors
Grant 10,668,035 - Chai , et al.
2020-06-02
Substituted Bisphenyl Butanoic Ester Derivatives As Nep Inhibitors
App 20190240177 - CHAI; Yongshuai ;   et al.
2019-08-08
Indoleamine-2,3-dioxygenase Inhibitor And Preparation Method Therefor
App 20190152932 - WANG; Zhaoyin ;   et al.
2019-05-23
Cyclic molecules as bruton's tyrosine kinase inhibitors
Grant 9,458,162 - Wang , et al. October 4, 2
2016-10-04
Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents
Grant 9,345,905 - Wang , et al. May 24, 2
2016-05-24
Spirocyclic molecules as protein kinase inhibitors
Grant 9,226,923 - Wang , et al. January 5, 2
2016-01-05
Heterocyclic molecules as apoptosis inducers
Grant 8,946,445 - Wang February 3, 2
2015-02-03
Ureas for the treatment and prevention of cancer
Grant 8,937,088 - Wang , et al. January 20, 2
2015-01-20
Cyclic Molecules As Bruton's Tyrosine Kinase Inhibitors
App 20150011530 - Wang; Zhaoyin ;   et al.
2015-01-08
Heterocyclic Amides Compounds Which Are Hdac6 Inhibitors And Used As Anti-tumoral Agents
App 20140322229 - Wang; Zhaoyin ;   et al.
2014-10-30
Heterocyclic Molecules As Apoptosis Inducers
App 20140256768 - Wang; Zhaoyin
2014-09-11
Spirocyclic Molecules As Protein Kinase Inhibitors
App 20140243303 - Wang; Zhaoyin ;   et al.
2014-08-28
Indole derivatives as CRTH2 receptor antagonists
Grant 8,637,541 - Wang January 28, 2
2014-01-28
Novel Ureas for the Treatment and Prevention of Cancer
App 20130296380 - Wang; Zhaoyin ;   et al.
2013-11-07
Fluoro Substituted Cycloalkanoindoles, Compositions Containing Such Compounds And Methods Of Treatment
App 20120115921 - Berthelette; Carl ;   et al.
2012-05-10
Indole Derivatives As Crth2 Receptor Antagonists
App 20110201641 - Wang; Zhaoyin
2011-08-18
Indole amide derivatives as EP4 receptor antagonists
Grant 7,968,578 - Boyd , et al. June 28, 2
2011-06-28
Substituted 2-naphthoic Acids As Antagonists Of Gpr105 Activity
App 20100298347 - Belley; Michel ;   et al.
2010-11-25
Substituted Fused Pyrimidines As Antagonists Of Gpr105 Activity
App 20100179173 - Guay; Daniel ;   et al.
2010-07-15
Novel Pharmaceutical Compounds
App 20100137371 - Berthelette; Carl ;   et al.
2010-06-03
Indole derivatives as CRTH2 receptor antagonists
Grant 7,696,222 - Wang April 13, 2
2010-04-13
Fluoro Substituted Cycloalkanoindoles, Compositions Containing Such Compounds And Methods Of Treatment
App 20100081696 - Berthelette; Carl ;   et al.
2010-04-01
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,502 - Berthelette , et al. November 24, 2
2009-11-24
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,501 - Dufresne , et al. November 24, 2
2009-11-24
Indole derivatives as crth2 receptor antagonists
App 20090286825 - Wang; Zhaoyin
2009-11-19
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
Grant 7,618,994 - Berthelette , et al. November 17, 2
2009-11-17
Indole Amide Derivatives as EP4 Receptor Antagonists
App 20090253756 - Boyd; Michael ;   et al.
2009-10-08
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
App 20080242722 - Dufresne; Claude ;   et al.
2008-10-02
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors
App 20080242643 - Dufresne; Claude ;   et al.
2008-10-02
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5h)-Furanones as Cyclooxygenase-2 Inhibitors
App 20080227758 - Berthelette; Carl ;   et al.
2008-09-18
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20080033028 - Berthelette; Carl ;   et al.
2008-02-07
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
Grant 7,317,036 - Berthelette , et al. January 8, 2
2008-01-08
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Grant 7,199,154 - Berthelette , et al. April 3, 2
2007-04-03
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,169,809 - Berthelette , et al. January 30, 2
2007-01-30
Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
Grant 7,144,913 - Wang , et al. December 5, 2
2006-12-05
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 7,060,715 - Dube , et al. June 13, 2
2006-06-13
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20060069148 - Berthelette; Carl ;   et al.
2006-03-30
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
Grant 7,019,022 - Beaulieu , et al. March 28, 2
2006-03-28
Nitric oxide releasing selective cyclooxygenase-2 inhibitors
App 20060058363 - Wang; Zhaoyin ;   et al.
2006-03-16
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
App 20050261245 - Berthelette, Carl ;   et al.
2005-11-24
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
App 20050154044 - Beaulieu, Christian ;   et al.
2005-07-14
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20050124680 - Berthelette, Carl ;   et al.
2005-06-09
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20050009875 - Dube, Daniel ;   et al.
2005-01-13
Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
App 20040180934 - Wang, Zhaoyin ;   et al.
2004-09-16
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
App 20040176331 - Berthelette, Carl ;   et al.
2004-09-09
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20030158246 - Berthelette, Carl ;   et al.
2003-08-21
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 6,596,736 - Dube , et al. July 22, 2
2003-07-22
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20030065011 - Dube, Daniel ;   et al.
2003-04-03
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
Grant 6,498,151 - Li , et al. December 24, 2
2002-12-24
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
App 20020091104 - Li, Chung Sing ;   et al.
2002-07-11
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
App 20020058644 - Leblanc, Yves ;   et al.
2002-05-16
Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
App 20020052346 - Lau, Cheuk Kun ;   et al.
2002-05-02
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase IB (PTP-IB)
App 20020052344 - Leblanc, Yves ;   et al.
2002-05-02
Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1B (PTP-1B)
Grant 6,365,592 - Leblanc , et al. April 2, 2
2002-04-02
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
Grant 6,329,421 - Prasit , et al. December 11, 2
2001-12-11
Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
App 20010016595 - Ducharme, Yves ;   et al.
2001-08-23
Battery charger for cellular phone, having speaker
App 20010006336 - Yi, Sang Yong ;   et al.
2001-07-05
Diaryl-2-(5H)-furanones as Cox-2 inhibitors
Grant 6,222,048 - Black , et al. April 24, 2
2001-04-24
Diaryl-5-alkyl-5-methyl-2-(5H)-furanones as selective cyclooxygenase-2-inhibitors
Grant 6,133,292 - Wang , et al. October 17, 2
2000-10-17
(methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors
Grant 6,071,954 - LeBlanc , et al. June 6, 2
2000-06-06
3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
Grant 6,057,319 - Black , et al. May 2, 2
2000-05-02
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 6,001,843 - Dube , et al. December 14, 1
1999-12-14
Alkylated styrenes as prodrugs to COX-2 inhibitors
Grant 5,925,631 - Black , et al. July 20, 1
1999-07-20
Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
Grant 5,922,742 - Black , et al. July 13, 1
1999-07-13
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 5,861,419 - Dube , et al. January 19, 1
1999-01-19
Stilbene derivatives useful as cyclooxygenase-2 inhibitors
Grant 5,849,943 - Atkinson , et al. December 15, 1
1998-12-15
Alkylated styrenes as prodrugs to COX-2 inhibitors
Grant 5,789,413 - Black , et al. August 4, 1
1998-08-04
Diphenyl stilbenes as prodrugs to COX-2 inhibitors
Grant 5,733,909 - Black , et al. March 31, 1
1998-03-31
Phenyl heterocycles as COX-2 inhibitors
Grant 5,710,140 - Ducharme , et al. January 20, 1
1998-01-20
3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors
Grant 5,698,584 - Black , et al. December 16, 1
1997-12-16
Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
Grant 5,691,374 - Black , et al. November 25, 1
1997-11-25
Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
Grant 5,552,422 - Gauthier , et al. September 3, 1
1996-09-03
Phenyl heterocycles as cox-2 inhibitors
Grant 5,550,142 - Ducharme , et al. August 27, 1
1996-08-27
Phenyl heterocycles as COX-2 inhibitors
Grant 5,536,752 - Ducharme , et al. July 16, 1
1996-07-16
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
Grant 5,521,213 - Prasit , et al. May 28, 1
1996-05-28
Phenyl heterocycles as cox-2 inhibitors
Grant 5,474,995 - Ducharme , et al. December 12, 1
1995-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed